Automating regulatory approval & compliance for life science companies
Company was acquired
Event Year: 2017
Company was acquired
Event Year: 2017
Enzyme offered a software-as-a-service (SaaS) solution designed to streamline quality management systems, coupled with expert consulting services in quality assurance and regulatory affairs. Their target audience was life science organizations navigating the complexities of FDA approval and maintaining ongoing compliance. The Enzyme team brought a wealth of experience, boasting over 50 years in the medical device sector, gleaned from both established Fortune 500 corporations and emerging startup ventures. This blend of software and expertise aimed to simplify a traditionally cumbersome and highly regulated process.
Enzyme offered a software-as-a-service (SaaS) solution designed to streamline quality management systems, coupled with expert consulting services in quality assurance and regulatory affairs. Their target audience was life science organizations navigating the complexities of FDA approval and maintaining ongoing compliance. The Enzyme team brought a wealth of experience, boasting over 50 years in the medical device sector, gleaned from both established Fortune 500 corporations and emerging startup ventures. This blend of software and expertise aimed to simplify a traditionally cumbersome and highly regulated process.
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2017
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2017
Healthcare
Healthcare
Healthcare -> Healthcare IT
Healthcare -> Healthcare IT
Team size: 32
Hiring: No
Team size: 32
Hiring: No